Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01IDD
|
|||
| Former ID |
DNC006606
|
|||
| Drug Name |
BAS-4844343
|
|||
| Synonyms |
BAS-4844343; CHEMBL207672; N-[5-(1H-indol-3-ylmethyl)-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide; AC1LK4AS; Oprea1_740559; MolPort-000-746-934; MolPort-001-911-292; ZINC17747698; STK758751; STK846597; BDBM50187576; AKOS005626974; AKOS000597970; MCULE-8653633709; BAS 04844343; SR-01000521375; SR-01000521375-1; A1870/0078659; N-[5-(1H-Indol-3-ylmethyl)-[1,3,4]thiadiazol-2-yl]-4-methoxy-benzamide; N~1~-[5-(1H-indol-3-ylmethyl)-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H16N4O2S
|
|||
| Canonical SMILES |
COC1=CC=C(C=C1)C(=O)NC2=NN=C(S2)CC3=CNC4=CC=CC=C43
|
|||
| InChI |
1S/C19H16N4O2S/c1-25-14-8-6-12(7-9-14)18(24)21-19-23-22-17(26-19)10-13-11-20-16-5-3-2-4-15(13)16/h2-9,11,20H,10H2,1H3,(H,21,23,24)
|
|||
| InChIKey |
AXHAJBIEOINPDH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors. J Med Chem. 2006 Jun 1;49(11):3278-86. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.